Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?

We discuss these results in the context of the literature on obesity and etiologic heterogeneity in breast tumors subtyped by sex hormone receptor status.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2025-11-05
DOI
https://doi.org/10.1158/1055-9965.epi-25-1007
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?

Stephen John Mooney, Andrew Graham Rundle
Cancer Epidemiology Biomarkers & Prevention
Cancer Risks and Factors
article

Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?

Stephen John Mooney, Andrew Graham Rundle
article en

Abstract

We discuss these results in the context of the literature on obesity and etiologic heterogeneity in breast tumors subtyped by sex hormone receptor status.

Cancer Epidemiology Biomarkers & PreventionVol. 35(1)
University of Washington (US), Columbia University (US)
Openalex Percentile: Top 56%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors? — Stephen John Mooney, Andrew Graham Rundle · Cancer Epidemiology Biomarkers & Prevention (2025) | TGRS Research Map | TGRS